- Immunex, the
developer of
Enbrel (etanercept). 2004: Also,
Amgen acquired Tularik,
another biotechnology company,
expanding the company's
research and development...
-
Steve McKnight and
Robert Tjian, he
founded Tularik in 1991, and was
their president and CEO
until Tularik was
acquired by
Amgen for $1.3
billion in 2004...
- and
Steve McKnight, co-founded
Tularik Inc., a
biotechnology company based in
South San Francisco, California.
Tularik was
acquired by
Amgen for $1.3...
-
affected individuals. In 1995,
after three years as
Director of
Research at
Tularik, Inc., a
South San Francisco-based
biotechnology company,
McKnight moved...
-
director at the
biotechnology company Tularik, Inc. from 1997 to 2001,
before it
being acquired by
Amgen in 2004.
Tularik went
public in
December 1999 and...
- Genentech's
molecular biology department; co-founder,
president and CEO of
Tularik, Inc.
Gerald Joyce, Ph.D. (Biology), 1984, scientist, Salk Institute; inventor...
-
Dentistry of New
Jersey Robert Wood
Johnson Medical School,
David Goeddel,
Tularik, Inc., and
Charles Weissmann,
Imperial College School of Medicine, London...
- Ph.D.
within 3 years. In 1995, he
entered David Goeddel's
laboratory at
Tularik. In 1998 he
became an ****istant
professor at the
Department of Immunology...
- Germany.
Between 1996 and 2015, he
served as head of drug
discovery at
Tularik Inc., as
chief scientific officer at
Micromet Inc., and as a vice president...
-
molecular biology approach the
research groups of
Carsten J.
Kirschning (at
Tularik Inc.) and
Douglas Golenbock (at
Boston University School of Medicine) in...
